计算溶液所需的质量、体积或浓度。
MEDI-3617 (anti-ANGPT2) (Ab183134) - ELISA
Immobilized human ANGPT2-chis at 2.0 μg/mL can bind MEDI-3617 (anti-ANGPT2) (Ab183134) with the EC50 of 31.65 ng/mL.
ExactAb™,低内毒素,已验证,无动物源,无叠氮钠,无载体,重组 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
MEDI-3617 (anti-ANGPT2) 是一种人单克隆抗体,针对血管生成细胞因子 angiopoietin-2 (Angpt2)。MEDI-3617 (anti-ANGPT2) 与 tremelimumab 联合用于治疗晚期黑色素瘤。
MEDI-3617 (anti-ANGPT2) is a human monoclonal antibody directed against the angiogenic cytokines angiopoietin-2 (Angpt2). MEDI-3617 (anti-ANGPT2) in combination with tremelimumab is used to treat advanced melanoma.
Purity
≥95% (SDS-PAGE&SEC)
Endotoxin Level
≤1.0EU/mg
Protein Function
Can induce tyrosine phosphorylation of TIE2. Binds to TIE2 receptor and counteracts blood vessel maturation/stability mediated by angiopoietin-1. Its function may be context-dependent. In the absence of angiogenic inducers, such as VEGF, ANG2-mediated loosening of cell-matrix contacts may induce endothelial cell apoptosis with consequent vascular regression. In concert with VEGF, it may facilitate endothelial cell migration and proliferation, thus serving as a permissive angiogenic signal.
MEDI-3617 (anti-ANGPT2) (Ab183134) - ELISA
Immobilized human ANGPT2-chis at 2.0 μg/mL can bind MEDI-3617 (anti-ANGPT2) (Ab183134) with the EC50 of 31.65 ng/mL.
MEDI-3617 (anti-ANGPT2) (Ab183134) - SEC
The purity of MEDI-3617 (anti-ANGPT2) (Ab183134) is more than 95% verified by HPLC.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab183134 | |
| 分析证书 | Ab183134 | |
| 分析证书 | Ab183134 |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Recombinant 级别指南 → 查看 Validated 级别指南 → 查看 ExactAb™ 级别指南 → 查看 Low Endotoxin 级别指南 → 查看 Azide Free 级别指南 →